Arie Belldegrun - 31 Aug 2022 Form 4 Insider Report for UroGen Pharma Ltd. (URGN)

Role
Director
Signature
/s/ /s/ Jason Smith, Attorney-in-Fact
Issuer symbol
URGN
Transactions as of
31 Aug 2022
Net transactions value
+$16,205
Form type
4
Filing time
02 Sep 2022, 11:40:33 UTC
Previous filing
29 Jun 2022
Next filing
16 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction URGN Ordinary Shares Options Exercise $16,205 +3,241 +1.3% $5.00 248,693 31 Aug 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction URGN Stock Option (right to buy) Options Exercise $0 -3,241 -100% $0.000000* 0 31 Aug 2022 Ordinary Shares 3,241 $5.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.